174
Peter Thiel, the billionaire tech investor and co-founder of PayPal and Palantir, is part of an investor group that holds a 7.5% stake in 180 Life Sciences, which is rebranding as ETHZilla, an Ethereum-focused corporate treasury vehicle, according to a new SEC disclosure. Shares of 180 Life Sciences (ATNF) jumped over 11% at Monday’s close and surged roughly 57% in overnight trading, Yahoo Finance data shows. 180 Life Sciences announced its Ethereum treasury plan in late July.
On Monday, the biotech firm said it sold $156 millionin senior secured convertible notes due 2028 to an institutional investor, following a recent $425 million private placement. Proceeds will primarily fund Ethereum purchases, yield-bearing assets, and the company’s iGaming operations, while monetizing legacy biotech IP. Thiel’s investor group now has stakes in two Ethereum treasury companies. In mid-July, he reported holding over 9% of Tom Lee’s BitMine Immersion, currently the biggest corporate ETH holder with close to $5 billion in its treasury.
You Might Be Interested In
- X to Launch Smart Cashtags, Letting Users Trade Crypto and Stocks Directly in the Timeline
- Bitcoin Surges Above $64,000 as Cooling U.S. Inflation Boosts Fed Rate Cut Expectations
- REX-Osprey Launches XRP and DOGE ETFs Trading Today
- Bitcoin Soars Past $72,000 to New All-Time High as Coinbase Shares Climb to Highest Since 2021
- Grayscale and CoinShares Target New Crypto ETFs Including Litecoin, Solana, and XRP
- Shiba Inu Surges 36% as South Korean Traders Ignite Mystery Rally












































































































































